Replies to post #693246 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

They have been unblinded now for years . They were unblinded when JAMA article was published

[manibiotech]

“they do not have to disclose results”

And of course market has absolutely loved and rewarded that strategy of staying quite and sharing minimum

[iclight]

Thank God because you are wrong.

That the DSMB chose to continue the trial, NOT HALT it.

Blatantly false. The DSMB recommends halts for safety, efficacy and futility. They report to the sponsor for futility or efficacy and the FDA for safety. Then the FDA halts the trial for safety or the sponsor chooses to halt it for efficacy or futility.